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Abstract
The perturbation of a transcription factor should affect the expression levels of its direct targets. However, not
all genes showing changes in expression are direct targets. To increase the chance of detecting direct targets, we
propose a modified two-group model where the null group corresponds to genes which are not direct targets, but
can have small non-zero effects. We model the behaviour of genes from the null set by a Gaussian distribution with
unknown variance τ2, and we discuss and compare three methods which adaptively estimate τ2 from the data: the
iterated empirical Bayes estimator, the truncated MLE and the central moment matching estimator. We conduct a
detailed analysis of the properties of the iterated EB estimate which has the best performance in the simulations.
In particular, we provide theoretical guarantee of its good performance under mild conditions.
We provide simulations comparing the new modeling approach with existing methods, and the new approach
shows more stable and better performance under different situations. We also apply it to a real data set from
gene knock-down experiments and obtained better results compared with the original two-group model testing for
non-zero effects.
1 Introduction
The transcriptional regulatory networks, formed by transcription factors(TFs) and their targets,
are believed to play an important role regulating embryonic stem(ES) cell pluripotency(Niwa et al.
(1998, 2000); Chambers and Smith (2004); Loh et al. (2006); Kim et al. (2008); Chen et al. (2008)).
A multitude of inference methods exist in the literature for the identification of such networks using
observational gene expression data(Friedman et al. (2000); Murphy et al. (1999); Kim et al. (2004);
Lebre et al. (2010)). On the other hand, there is also intense interest in using perturbation experi-
ments in the study of gene regulation. For example, the TF knock-down experiment is expected to
very informative identifying potential targets of a TF because it depicts a less complex picture and
can provide evidence for causal relationships(Geier et al. (2007); Werhli et al. (2006)).
Traditionally, potential targets of the TF are usually identified as the subset of differentially
expressed genes between the control and experiment group. However, when an important TF has
been knocked down, it is almost always the case that the proportion of significantly changed genes is
much larger than expected(Ivanova et al. (2006); Zhou et al. (2007)). As a concrete example, consider
the data set analyzed in this study, which is from the knockdown experiment for two TFs which play
an important role regulating embryonic stem (ES) cell pluripotency(see section 6 for details). In this
data set, the number of differentially expressed genes is very large, while the number of likely direct
targets (from external CHIP-seq data assessing TF binding) is significantly smaller.
There are two popular explanations for this phenomenon:
1. The theoretic null distribution of the test statistics(often z-score and other analogous quantities)
for zero effect is not accurate.
2. There are a large number of genes showing non-zero but small changes of gene expression level,
as effects of the perturbation.
Proposed solutions include modifying the null distribution of z-score empirically(Efron (2007, 2008))
and applying a cut-off to fold-change as a second-layer filter; the latter has been extremely popular in
practice(Nichols et al. (1998); Zhou et al. (2007); Vaes et al. (2014)). While both of these approaches
can narrow down the selected, the former tackles the problem mainly based on the first explanation
while the latter adopts the second implicitly, and results can be different in general(Witten and
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Tibshirani (2007)). For the knockdown experiment, the latter seems preferable because it considers
both the change magnitude and the non-zero significant level, which is more related to what scientists
care about; however, this approach lacks a natural quantitative justification.
Here, we propose a simple model to combine these two perspectives. By using a Gaussian distribu-
tion with unknown variance to describe the underlying behavior of genes in the null group, our model
assumes that there can be relatively small non-zero effects even for the null genes. Assuming that the
number of genes with large effect size is small, we test for the presence of such large effects relative
to the background null variance. Although this model is motivated by the knockdown experiment,
it can be applied to more general multiple-testing setting where both the significance and the effect
size matter.
Our approach is related to the method of maximal agreement cut by Henderson and Newton
(2015). They similarly pointed out that testing approaches which measure evidence against the null
hypothesis tend to over-populate the candidate list with those associated with small variance, while
approaches that consider only the magnitude will overlook the noise. While sharing the same spirit,
our method does not aim to find the top α% subset of genes maximizing the expected overlap with
the truth, with some assumed prior for all genes. Instead, we are interested in identifying the subset
of genes which could not be described well by the prior describing the majority.
In the setting of knock-down experiment, our model describes a scenario different from the one
assumed in approaches testing for differentially expressed genes. In our model, it is assumed that,
perhaps due to propagation through the gene regulatory network, when we collect the data, a lot
and even all genes may have been influenced once a TF has been knocked down, and we take this
possibility into consideration. We show that in this scenario, it is still possible to test for strong effect
if (1) the direct target tends to have larger effect size, and (2) there are enough null hypotheses to
estimate the variance under the null.
The paper is organized as follows: We describe our model in section 2.1 and procedures to estimate
the null variance in section 2.2. In section 3, we study the properties of one τ 2 estimating procedure;
in section 4, we extended the model to the non-centered case and the case of two sample testing with
unequal variance. We provide simulations in section 5 and real data examples in section 6.
2 Statistical model and estimation procedure
2.1 Statistical model
We assume there is a control group with m0 replicates and an experiment group with m1 replicates
after knocking down one TF of interest. The expression levels for N genes are measured for each
replicate. Let xi,j be the measurement for gene i in replicate j from the experiment group, and zi,j be
the measurement for gene i in replicate j from the control group. Without loss of generality, assume
the mean level of zi,j is 0 and the mean level of xi,j is µi:
xi,j ∼ N(µi, σ2i ), ∀i = 1, 2, ..., N, j = 1, 2, ...,m1
zi,j ∼ N(0, σ2i ), ∀i = 1, 2, ..., N, j = 1, 2, ...,m0
To do inference on µi, we can look at the two-sample test statistics,
x¯i − z¯i =
∑m1
j=1 xi,j
m1
−
∑m0
j=1 zi,j
m0
∼ N(µi, σ2i (
1
m1
+
1
m0
)), ∀i = 1, 2, ..., N
Or the paired sample test statistics to remove the batch effect (m0 = m1),
xi − zi =
∑m1
j=1(xi,j − zi,j)
m1
∼ N(µi, σ2i
1
m1
), ∀i = 1, 2, ..., N
2
As there is no fundamental difference between these two tests in our later analysis, we will omit
the notation zi and use the following common notations for simplicity:
x¯i ∼ N(µi, σ2x¯i), ∀i = 1, 2, ..., N
σˆ2x¯i ∼ σ2x¯i
χ2m−k
m− k ,∀i = 1, 2, ..., N
where σ2x¯i =
σ2i
n
, with n being the effective sample size and σˆ2x¯i is the usual unbiased variance estimate
of x¯i. In the two-sample case, n =
m1m0
m
, m = m1 + m2, k = 2 and in the paired sample case,
n = m = m1, k = 1.
Following the widely used two group model(Efron (2008)), let A0, A1 denote the sets of nulls and
non-nulls respectively and γ = |A1|
N
denote the proportion of non-nulls. We assume that the µis in
A0 and A1 are generated from different distributions:
µi ∼
{
N(0, τ 2) ∀i ∈ A0
gi(.) ∀i ∈ A1
For each gene i ∈ A1, gi is some unknown density function. The parameter τ can be viewed as
describing the range of normal behaviour.
In contrast to the original two-group model, which corresponds to τ = 0, we allow τ to take
positive values. By relaxing this assumption on τ , we are able to detect relatively abnormal behavior
compared with the background signal. If we know τ , the p-value for the new null hypothesis for gene
i can be derived. Let ui =
x¯i√
τ2+σˆ2x¯i
, x¯i ∼ N(0, τ 2 + σ2x¯i), under the null hypothesis, ui is a Welch
statistics(Welch (1947)) in the limit case with the degree of freedom for the first “variance estimate”
τ 2 being∞. Usual analysis controlling False discovery rate (FDR) or family wise error rate (FWER)
carries through under our extended model in this case.
We emphasize that the parameter τ itself is informative because it characterizes how influential a
stimulus is – in our case, how dramatically the whole system changes after we have knocked down a
TF. The value of τ reflects the importance of the TF: it can be set according to either prior knowledge
or estimated from the data. The second approach is usually more feasible, as we lack a quantitative
characterization of this kind of importance, and it can vary under different environments even for
the same TF.
2.2 Estimation procedure
In this paper, we propose and compare three methods estimating τ 2: an iterated empirical Bayes
estimate(ITEB) method, the truncated MLE method and the central matching(CM) method. The
latter two methods have also been applied to estimating the empirical null distribution in the tradi-
tional two group test problem(Efron (2012); Efron et al. (2001)), and we have adapted them to our
problem here. ITEB is a new method that we develop for our problem.
For i ∈ A0, x¯i ∼ N(0, σ2x¯i + τ 2) marginalizing out µi. If A0 is known, the empirical Bayes estimate
of τ 2 with estimated variance σˆ2x¯i for σ
2
x¯i
is given by τˆ 2A0 =
1
|A0|
∑
i∈A0(x¯
2
i − σˆ2x¯i). Let δ be a pre-
determined small value, the adjusted form τˆ 2A0 = [
1
|A0|
∑
i∈A0 x¯
2
i − (1 + δ)σˆ2x¯i ]+, is often preferred to
reduce the error for small τ 2 and to ensure non-negativity. Similar form of estimate is analyzed
by Johnstone (2001b,a) in the context of estimating non-centrality of χ2-distribution with known
variance.
Let Fi(.) denote the distribution of
x2i
τ2+σˆ2x¯i
when i ∈ A0, which is the distribution of the square of
a Welch’s statistic as mentioned before, and F˜i(x) = 1− Fi(x). The ITEB procedure is given below,
which starts from the whole set (as A0 ∪ A1) and then iteratively remove potential outliers on the
tail based on the current estimate of τ 2. It stops when no point needs to be further removed.
3
Iterated empirical Bayes estimation(ITEB) of τ2
Input: {(x¯i, σ2x¯i), ∀i = 1, 2, ..., N}, significance level α1, α2 and δ. By default, α1 = 0.1, α2 = 0.01 and δ =
√
8
N
.
Output: τˆ2, the estimated τ2.
Initialization: S0 = {1, 2, . . . , N} be the initial estimate of the null set, and τˆ2S0 =
[
∑N
i=1 x¯
2
i−(1+δ)
∑N
i=1 σˆ
2
x¯i
]+
N
.
For k = 1, 2, ..., do
1. Update the p value for each gene pi = F˜i(
x¯2i
τˆ2
Sk−1+σˆ
2
x¯i
). The ordered p values from small to large are p(1), p(2), . . . , p(N).
Let i∗ be the largest index, such that p(i∗) ≤ i∗N α1.
2. Let J1k = {i ∈ A : pi ≤ p(i∗)}, and J2k = {i ∈ A : pi ≤ α2} and remove Jk := J1k ∩ J2k . Update Sk = Sk−1/Jk and
τˆ2Sk =
[
∑
i∈Sk x¯
2
i−(1+δ)
∑
i∈Sk σˆ
2
x¯i
]+
|Sk| .
3. If Sk = Sk−1, return τˆ2 = τˆ2Sk
The detailed descriptions of the truncated MLE and the CM estimator are given in Appendix C.
In Appendix D, we compare performances for the three estimators in different scenarios and discuss
their strengths and weaknesses. ITEB was found to have better performance overall, especially when
the non-null proportion γ is small. Thus, we will focus on ITEB and we provide detailed analysis of
its properties.
3 Properties of ITEB
We study the estimation quality of ITEB as the number of hypotheses N → ∞. For simplicity,
we analyze the algorithm under following mild conditions and notations with δ = 0. Let λ(α) :=
maxi F˜
−1
i (α). The degree of freedom for the variance estimate is m for all i, and K := the number of
iterations needed for the algorithm to stop. Since in this section we only use the mean level x¯i and
its estimated variance σˆ2x¯i , with slight abuse of notation, let xi := x¯i, σˆ
2
i := σˆ
2
x¯i
, σ2i := σ
2
x¯i
. For the
two levels α1 and α2 in the ITEB algorithm, we let 0 < α1 <
1
2e
be a fixed value, and we let α2 → 0
at a slow rate to simplify the notations in the proof(we always let Nα2
log2N
bounded away from 0).
Assumption 3.1. The degree of freedom for variance estimates m ≥ 5 is a constant and the non-
null proportion γ < 1 − c for some positive constant c. The ratio of variances of different genes is
bounded: there exists a positive constant C such that
maxi σ
2
i
mini σ2i
≤ C.
Without loss of generality, we rescale mini σ
2
i = 1, then C = maxi σ
2
i . We do not require τ
2 to be
positive or a constant. It can be 0 or decay to 0 as N →∞.
Assumption 3.2. There exists constants L and , such that
∀i ∈ A1, E[x2i − (1 + )σˆ2i | x2i − (1 + )σˆ2i ≤ L(τ 2 + 1)] ≥ (1 + )τ 2
Remark 3.3. If i ∈ A0, we have E[x2i − σˆ2i ] = τ 2. Assumption 3.2 states that, for i ∈ A1, x2i − σˆ2i
has expectation non-negligibly bigger than τ 2 and this condition is not purely driven by observations
from its tail.
Assumption 3.4. The non-null proportion γ → 0 as N →∞.
Theorem 3.5. (Lower bound of the variance estimate) Let RK := |JK ∩A1|, where JK is the rejected
set at the last step k = K from ITEB. Let ∆1 =
√
logN
N
(τ 2 + C), tl = max(
log2N
N
,min( l
N
, 2α2)),
∆2,l = 3(τ
2 + C)tl log
1
tl
and τ 2l = [τ
2 − ∆1 − ∆2,l]+. Under Assumption 3.1 and 3.2, we have
P (∪Nγl=0{RK = l, τˆ 2 ≥ τ 2l })→ 1.
4
As
∆1+∆2,l
τ2+C
→ 0 for all l, Corollary 3.6 is a direct result of Theorem 3.5.
Corollary 3.6. Under Assumption 3.1 and 3.2, for any δ > 0, limN→∞P (τˆ 2 ≥ [τ 2−δ(τ 2+C)]+) = 1.
Theorem 3.7. (Upper bound of the variance estimate) Under Assumption 3.1 and 3.4, suppose
α1 > 0 is fixed and α2 → 0 at a rate slow enough: γλ(α2) → 0. Then, for any δ > 0, we have
limN→∞ P (τˆ 2 ≤ τ 2 + δ(τ 2 + C)) = 1.
We next show that these results can usually lead to good performance in the follow-up analysis
in practice. Theorem 3.8 states that our estimate of τ 2 can successfully control the FDR if we reject
the hypotheses in the set JK .
Theorem 3.8. (FDR control) Under Assumption 3.1 and 3.2, if we reject all hypothesis in JK, we
have limN→∞ FDR ≤ α1.
Remark 3.9. Note that at the given level α1, α2 in the ITEB algorithm, J
1
K will correspond to the set
of rejections using the BH(Benjamini-Hochberg procedure)(Benjamini and Hochberg (1995)) and JK
will correspond to the set of rejections which are both rejected by the BH procedure and with p-values
no greater than α2. The extra requirement that the p-value is no greater than a reasonable small value
α2 is desirable in a lot of large scale hypotheses testing setting, including the knock-down experiment.
Theorem 3.10. (Power analysis) Let φi,α = 1pi≤α and let φ
∗
i,α be the oracle decision rule knowing
τ 2: for any level α, φ∗i,α = 1x2i>F˜−1i (α)(σˆ2i+τ2). Let z
2
i =
x2i
τ2i +σ
2
i
where τ 2i = E[µ
2
i ] for i ∈ A1. Under
Assumption 3.1 and 3.4, if we further assume that the density of z2i is upper bounded by a constant,
and the tail probability for z2i decays sufficiently fast:
lim
w→∞
sup
δ>0
sup
i∈A1
P (z2i ≤ w(1 + δ))
P (z2i ≤ w)(1 + δ)
≤ 1
Then we have limN→∞ supi∈A1 supα≥0(P (φi,α = 1)− P (φ∗i,α = 1)) ≥ 0.
Remark 3.11. Recall that the follow-up p value pi for hypothesis i is F˜
−1
i (
x2i
τˆ2+σˆ2i
). Thus Theorem
3.10 says that the test φi based on the estimated variance τˆ
2 is asymptotically as powerful as the
optimal test based on the (unknown) true variance τ 2.
Proofs of Theorem 3.5, 3.7, 3.8 and 3.10 are given in the Appendix A.
4 Extension to two sample test with unequal variance
For hypothesis i, the observations from the experiment and control groups, xi,j and zi,j, can have
different variances. It is straightforward to generalize ITEB to this situation if we want to perform
a two-sample test. We know that ITEB takes in {x¯i − z¯i} and {σˆ2x¯i−z¯i}. In the unequal variance
setting, we can estimate σˆ2x¯i−z¯i by:
σ2x¯i−z¯i =
∑m1
j=1(xi,j − x¯i)2
m1(m1 − 1) +
∑m0
j=1(zi,j − z¯i)2
m0(m0 − 1)
The degree of the σˆ2x¯i−z¯i approximated by
dfσ =
(
∑m1
j=1(xi,j−x¯i)2
m1
+
∑m0
j=1(zi,j−z¯i)2
m0
)2
1
(m1−1)(
∑m1
j=1(xi,j−x¯i)2
m1
)2 + 1
(m0−1)(
∑m0
j=1(zi,j−z¯i)2
m0
)2
5
We approximate Fi(.),the distribution of the test statistics
(x¯i−z¯i)2
τ2+σ2x¯i−z¯i
, by F1,df (.), the F distribution
with degree of freedoms (1, df)(Satterthwaite (1946)), where df is approximated by df = ( τ
2
σ2x¯i−z¯i
+
1)2dfσ.
5 Simulation: Detection of large signal
We consider the two-sample setting with equal-variance and generate data under various values of τ
and non-null proportion γ = |A1|
N
. Specifically, we fix N = 15000, m = 5 for both the control and
experiment group, for any given τ and γ, where γ = 1%, 5% and τ = 0, 0.1, ..., 1, 1.5, 2, 2.5, 3, we
generate the true mean and variance as below.
1. Let µi = 0 in the control group, and in the experiment group, we generate them as following:
µi ∼
{
N(0, τ 2) ∀i ∈ A0
±U [1,max(3, 10τ)] ∀i ∈ A1
where U [1,max(3, 10τ)] is the uniform distribution between 1 and max(3, 10τ), and the signs of
µis will be half positive and half negative.
2. We sample the variances σ2i from its empirical distribution from the real data set, and we scale
them to have mean level 1.
We compare the following approaches:
• ITEB estimate of τ 2 and followed the Welch’s t-test as previously described.
• t-test for the null hypothesis testing for zero effect
• EBarray(two group empirical Bayes method with each gene being either differential expressed or
not),(Kendziorski et al. (2003); Yuan and Kendziorski (2006)), and we choose the “LLN” model
to fit the data. Different genes are considered to have a common variance in the null group(or
in the non-null group).
• EBarray, and we choose the “LLNMV” method to fit the data. Different genes are considered
to have difference variances with the inverse chi-square prior.
Figures (1) and (2) provide ROC curves(average sensitivity versus FDP) across 20 repetitions as
the significant level in the testing step is varied. We see that the new approach performs the best
across different experiments. When τ = 0, ITEB procedure and t-test behave similarly and have the
best performance, and the same thing happens for ITEB and EBarray with “LLN” method when τ
is large. ITEB and EBarray with “LLNMV” method are both stable across a wide range of τ , but
the ITEB procedure is more powerful in our simulations.
6 Real Data Examples
In this section, we apply our approach to data from two knock-down experiments described below.
The quality of the results are evaluated by the enrichment of ChIP-seq peaks (for the perturbed TF)
in active enhancers/promoters for the selected genes. Note that the ChIP-seq data for ES cells are
external to the data used to select the genes, and it provides an orthogonal information to access
how likely the selected genes are direct targets of the TFs.
We perform gene knock-down experiments on 2 TFs on the mouse ES cell line R1. For each
TF, RNA interference (RNAi) delivered using nucleofection was used to knock down its expression.
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Figure 1: ROC curve for p = 1%.
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Figure 2: ROC curve for p = 5%.
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Table 1: Information of the knock-down data sets.
30 hr 48 hr 72 hr
POU5F1 4 pairs 4 pairs –
NANOG 2 pairs 4 pairs 2 pairs
Puromycin selection was introduced 18 h later at 1 µ g/ml, and the medium was changed daily. 30
h, 48 h, and 72 h after puromycin selection, the cells were collected for RNA isolation. After the
experiments, Microarray hybridizations were performed on the MouseRef-8 v2.0 expression beadchip
arrays (Illumina, CA). More details of the experiments can be found in Appendix E. Quantile nor-
malization is performed in the first step to reduce the batch effect, and for the same reason, for each
sample in the experiment group, we consider the paired test statistics with each pair being a pair
of independent experiment and control samples from the same batch and time point. We have 8
paired observations for both POU5F1 and NANOG, and we take the log difference between the gene
expression levels in a knock-down sample and its corresponding control sample to further reduce
the batch effect. Table 1 summarizes the data we have at different time points. Figure 3 shows
results from nine realizations of the t-SNE(Maaten and Hinton (2008)) plot using the top 1000 genes
with largest variance across experiments. Each data point in the t-SNE plot represents one sample
(paired) in the experiment. We use the colors black, red and green to represent data at time points
30 hr, 48 hr and 72 hr respectively. From the results, we see that differences between time points
within the same knock-down experiment is comparable to the differences across batches, and they
are very small compared with the differences across knock-downs . To compare the targets of two
TFs, we will regard the different times points in the same knock-down as replicates of each other.
ChIP-seq data and enhancer-gene association data: To evaluate the quality of the selected
gene set, we utilize two external data sets: the ChIP-seq data is from Chen et al. (2008) and the
enhancer-gene association data is from Mumbach et al. (2017). The ChIP-seq data contains results
using chromatin immunoprecipitation coupled with ultra-high-throughput DNA sequencing (ChIP-
seq) to map the binding locations of 13 sequence-specific TFs, including POU5F1 and NANOG.
The enhancer-gene association data is generated by using the HiChIP method where the authors
performed H3K27ac HiChIP in mouse ES cells. H3K27ac is a histone modification mark charac-
teristic of active enhancers and promoters in the cell. HiChIP using H3K27ac mark as bait will
provide enhancer-gene interaction information. We can evaluate the quality of the selected gene
set by examining whether the binding sites of POU5F1 and NANOG are enriched near the active
enhancers/promoters of the selected genes in the ES cell.
Let us call the approach based on p-value using a simple t-test S0, and the approach based on p-
value using ITEB S2. We will focus on those genes with significant decrease in their expression levels
after POU5F1/NANOG knock-down. For each method, we set the cut-off using the BH procedure
with targeted FDR level at 0.01. Accordingly, we set the the cut-off level α1 = 0.01 and we select
87 genes after knocking down POU5F1 and 43 genes after knocking down NANOG using S2. These
numbers are 2274 and 1267 using S0. S0 does not provide informative candidate lists with this
criterion. To have a meaningful comparison, we also consider the case where we control FWER at
0.01, which is quite a stringent criterion and under which, S0 selects 144 genes for POU5F1 and 49
genes for NANOG.
We say that there is supporting evidence of a gene being a direct target of a TF if this TF has at
least one ChIP-seq peak within x kilobase(kb) away from the gene’s active enhancers/promoter. As
we change x in a large range of value, Figure 4 gives the percentages of genes with this supporting
evidence in the selected gene sets using S0 using FWER and S2 using FDR. Figure 4 also shows
the percentages of all genes with this supporting evidence(referred to as “all” in the figure), and
the percentages of bottom 2000 genes with this supporting evidence(referred to as “bottom”). The
bottom 2000 genes are those showing the smallest change after knock-down experiment(we consider
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Figure 3: Clustering with t-SNE algorithm. Black, red, and green colors represent experiments from 30 hr, 48 hr and
72 hr respectively. Note that there are two replicates from the same batch in a single experiment (same day, same TF,
same batch) that are almost identical to each other.
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Figure 4: Percent of genes with ChIP-seq nearby versus x for the selected gene sets (S0: genes selected using t-test
with FWER control, S2: genes selected based on ITEB with FDR control, bottom: the bottom 2000 genes which show
the smallest changes, all: all genes). The x-axis is the log(x), the threshold we use to define whether a gene has a
ChIP-seq peak near its enhancer/promoter and the y-axis is the percentage of selected genes with ChIP-seq nearby.
this set to be the negative control). From Figure 4, we see that the ChIP-seq enrichment is quite
significant for the selected genes comparing with both the negative controls and all genes. The
selected gene set using S2 is significantly better than the gene set selected using S0. Table 2 shows
the result with x = 20.
Table 2: S0, S2 results with FDR/FWER level set at 0.01
TF percent(negative control) size(S0 ) percent(S0) size(S2) percent(S2)
FDR POU5F1 0.21 2274 0.48 87 0.73
NANOG 0.32 1267 0.62 43 0.81
FWER POU5F1 0.21 144 0.62 31 0.74
NANOG 0.32 49 0.74 20 0.8
The first, third and fifth column are the percent of genes with Chip-seq+Hi-C support of the negative control set,
genes selected by S0 (blue, genes selected by t-test) and S2 (red, genes selected based on ITEB) respectively.
Not only S2 provides a candidate gene set with much smaller size and higher quality, it provides
a gene ranking list different from S0. We fix x = 20 and consider the top k genes using S0 and S2.
Figure 5 shows that S2 provides a ranking list with higher quality.
7 Discussion
In this paper, motivated by the problem of identifying TF targets based on data from the knock-down
experiment, we have proposed to test for large effect size instead of non-zero effect size in the two-
group model where a Gaussian distribution with non-zero variance is used for the effect in the null
group. We have considered three approaches(ITEB, truncated MLE and CM) to estimate this non-
zero variance adaptively, and recommend ITBE for its computational efficiency, strong performance
in simulation and attractive theoretical properties. Although we have focused on the Gaussian setting
here, the idea of testing for strong signal and the approaches to estimate the null distribution can be
applied to problems involving other data types.
The model itself is related to the “g-modeling”(Carroll and Hall (1988); Efron (2014)), the “-
contamination”(Huber (1964); Chen et al. (2016)) and the “robust Bayesian analysis”(Berger and
Berliner (1986); Gaver and O’Muircheartaigh (1987); Berger et al. (1994)). However, it should be
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Figure 5: Percent of genes with ChIP-seq nearby versus versus selected gene size. The x-axis is k, the threshold of the
ranking on the whole list created using S0 and S2, and we only consider the top k genes from each ranking list.
noted that our approach has a different goal from the g-modellings. We only estimate the shape of
the null distribution of the mean parameter while the g-modeling models the marginal distribution
of the mean parameter considering both the nulls and the non-nulls. Our purpose for estimating
the null effect distribution is to set a cut-off for the strong signals adaptively, which is not the case
for the g-modelling. Although our model can be considered as a special case of the -contamination
model in the parameter space and a special case of the robust empirical Bayesian analysis, the use
of these models for large effects have not been studied and, to the best of our knowledge, methods
with provable guarantees on power and FDR have not been demonstrated previously.
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A Proof of Theorem 3.5, Theorem 3.7, Theorem 3.10 and Theorem 3.8
Let ∆1 :=
√
logN
N
(τ 2 + C), and let tl := max(
log2N
N
,min(2α2,
l
N
)), ∆2,l := 3(τ
2 + C)tl log
1
tl
, τ 2l :=
[τ 2 − ∆1 − ∆2,l]+ for all l = 0, 1, . . . , |A1|. Let the oracle estimator be defined as τ 2∗ =
∑
i∈A0 x
2
i−σˆ2i
|A0| .
Let pi,l = F˜ (
x2i
τ2l +σˆ
2
i
) be the p-values calculated using τ 2l and let p(i),l be the ordered null p-values
from small to large. Let B1,l = {i ∈ A0 : pi,l ≤ p(s0),l}, where s0 = max{s : p(s),l ≤ (s+l)α1N }, and
B2,l = {i ∈ A0 : pi,l ≤ α2}. Lemma A.1 contains the deterministic relationships we will use later.
Lemma A.1. Suppose 0 < α1 <
1
2e
to be fixed and α2 → 0 at a slow rate (α2 Nlog2 N is bounded away
from 0). Under Assumption 3.1, the following statements hold:
(1)λ( lα1
N
) . (N
l
)
2
5 , ∆1
τ2+1
λ(α1
N
)→ 0, supl≥1 ∆2,lτ2+1λ( lα1N )→ 0, supl≥0
∆2,l
τ2+1
λ(α2)→ 0
(2)limN→∞ supi∈A0 supl≥0 supα≥min
(
α2,
(l∨1)α1
N
) P (pi,l≤α)
α
= 1
(3)The estimate τˆ 2Sk is non-increasing in the iteration number k in the ITEB procedure.
Proof of A.1 is deferred to section B.
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Proof of Theorem 3.5
Proof. Let Ek,l := {τˆ 2Sk ≥ τ 2l }. Because ∪
|A1|
l=0 {RK = l} is a partition of the full space, to prove the
statement, we show the following:
P (∪|A1|l=0 {RK = l, EcK,l}) ≤ P (∪|A1|l=0 {RK ≤ l, EcK,l})→ 0
Define Rk := |Jk ∩ A0| for each iteration k. We also let R0 = 0, and Rk−1 ≤ Rk as a consequence
of Lemma A.1, part (3). We prove it by showing that the events {Rk ≤ l, Eck,l, Ek−1,l} and {Ec0,l} do
not happen on a properly chosen event M which itself happens with probability approaching 1. The
existence of such M is sufficient for our argument:
|A1|∑
l=0
P ({RK ≤ l, EcK,l,M}) ≤
|A1|∑
l=0
P (RK ≤ l, EcK,l, EK−1,l,M) +
|A1|∑
l=0
P (RK ≤ l, EcK−1,l,M)
≤
Nγ∑
l=0
P (RK−1 ≤ l, EcK−1,l,M) ≤ . . . ≤
|A1|∑
l=0
P (Ec0,l,M) = 0
Then P (∪|A1|l=0 {RK ≤ l, EcK,l}) ≤ P (∪|A1|l=0 {RK ≤ l, EcK,l,M}) + P (M c) → 0. We now find M which
contradicts {Rk ≤ l, Eck,l, Ek−1,l} and {Ec0,l}. Let S0k = A0 ∩ Sk and S1k = A1 ∩ Sk be the set of nulls
and non-nulls remaining at iteration k. The relationship below always holds:
τˆ 2Sk ≥
[|A0|τ 2∗ −
∑
i∈A0\S0k x
2
i +
∑
i∈S1k(x
2
i − σˆ2i )]+
|S0k |+ |S1k |
In other words,
{Eck,l, Ek−1,l, Rk ≤ l} ⊆ {
[|A0|τ 2∗ −
∑
i∈A0\S0k x
2
i +
∑
i∈S1k(x
2
i − σˆ2i )]+
|S0k |+ |S1k |
< τ 2l , Ek−1,l, Rk ≤ l}
If τ 2l ≤ 0, the above event will never happen, hence,
{Eck,l, Ek−1,l, Rk ≤ l} ⊆ {|A0|τ 2∗ −
∑
i∈A0\S0k
(x2i − τ 2l ) +
∑
i∈S1k
(x2i − σˆ2i − τ 2l ) < τ 2l |A0|, τ 2l > 0, Ek−1,l, Rk ≤ l}
When Ek−1,l happens and when Rk ≤ l, the removed nulls A0 \S0k must be in the set Bl := B1,l∩B2,l
for the following reasons. A0 \ S0k ⊆ B2,l by definition. Now, we let p∗ := |J
1
k |α1
N
be the cut-off for the
rejected p-values for the set J1k . There are two possibilities : p∗ ≤ α2 or p∗ > α2. We discuss them
separately.
1. If p∗ ≤ α2, the rejected set from ITEB will be the set J1k and J1k contains at most l non-null
hypothesis. Suppose J1k contains exactly s0 null hypotheses. In order for any null hypothesis i
to be rejected, it must satisfy pi ≤ (s0+l)α1N , and we know there are s0 of them. As a result, we
know s0 = |{i ∈ A0 : pi ≤ (s0+l)α1N }|. When Ek−1,l happens, we have pi ≥ pi,l, thus s0 ≤ |{i ∈
A0 : pi,l ≤ (s0+l)α1N }| or p(s0),l ≤ (s0+l)α1N . As a result, we have s0 ≤ arg max{s : p(s),l ≤ s+lN α1}
and A0 \ S0k ⊆ B1,l. Hence, A0 \ S0k ⊆ Bl.
2. If p∗ > α2, the rejected set from ITEB will be the set J2k . In this case, we can show that
B2,l ⊆ B1,l. Because pi,l ≤ pi, everything in J1k will again be rejected if we replace pi with pi,l, in
other words, |B1,l| ≥ |J1k |. As a result, p∗∗, the new cut-off p-value for B1,l, will be larger than
α2: p∗∗ ≥ |J
1
k |α1
N
> α2, which in turns lead to the fact that B2,l ⊆ B1,l and Bl = B2,l. Hence,
A0 \ S0k ⊆ Bl.
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Let A˜1,l := {i ∈ A1 : pi,l ≥ α2}. When Ek−1,l holds, A˜1,l ⊆ S1k , and for any i ∈ Bl or i ∈ A1 \ A˜1,l, we
have x2i ≥ F˜i(α2)(τ 2l + σˆ2i ), thus (x2i − σˆ2i ) > τ 2l , and
{Eck,l, Ek−1,l, Rk ≤ l} ⊆ {|A0|τ 2∗ −
∑
i∈Bl
(x2i − τ 2l ) +
∑
i∈A˜1,l
(x2i − σˆ2i − τ 2l ) < τ 2l |A0|, τ 2l > 0}
We can construct M based on the equation above. We define the following six events:
M1 = {∀l = 0, 1, . . . , |A1| : |B1,l| ≤ (log
2N ∨ l)
N
|A0|},M2 = {∀l = 0, 1, . . . , |A1| : |B2,l| ≤ 2α2|A0|}
M3 = {∀l = 0, 1, . . . , |A1| : ( max
Aα⊆A0:|Aα|≤tl|A0|
∑
i∈Aα
x2i ) ≤ 2.5(τ 2 + C)tl|A0| log
1
tl
}
M4 = {∀l = 0, 1, . . . , |A1| :
∑
i∈A˜1,l
(x2i − σˆ2i − τ 2l ) ≥ −(τ 2 + 1)(1− γ)
√
|A1| logN}
M5 = {
∑
i∈A1
(x2i − σˆ2i − τ 2) ≥ −(τ 2 + 1)(1− γ)
√
|A1| logN}, M0 = {|τ 2 − τ 2∗ | ≤ (1−
√
γ)∆1}
Let M = ∩5j=0Mj. Lemma A.2 states that M happens with probability approaching 1, whose proof
is deferred to section B.
Lemma A.2. Under Assumption 3.1 and Assumption 3.2, with α1 <
1
2e
being a positive constant
and α2 → 0 at a slow rate (α2 Nlog2N is bounded away from 0), M0, M1, M2, M3, M4 and M5 happen
with probability approaching 1.
When M1 and M2 hold, we have |Bl| = |Bl,1 ∩B2,l| ≤ tl|A0|, and if M3 also holds, we have∑
i∈Bl
x2i ≤ max
Aα∈A0,|Aα|≤tl|A0|
∑
i∈Aα
x2i ≤ 2.5(τ 2 + C)|A0|tl log(
1
tl
) ≤ 5
6
|A0|∆2,l
When M5 holds, we have
∑
i∈A˜1,l(x
2
i − σˆ2i − τ 2l ) ≥ −
√
γ|A0|∆1. Therefore, the following is true,
{Eck, Ek−1, Rk ≤ l,M} ⊆ {|A0|(τ 2 − (1−
√
γ)∆1)− 5
6
|A0|∆2,l −√γ|A0|∆1 < |A0|τ 2l , τ 2l > 0}
= {(τ 2 − (1−√γ)∆1)− 5
6
∆2,l −√γ∆1 < (τ 2 −∆1 −∆2,l)}
= {5
6
∆2,l > ∆2,l} = ∅
In the step 0, we use all points to estimate τˆ 2S0 =
|A0|τ2∗+
∑
i∈A1 (x
2
i−σˆ2i )
N
. When M0 holds, we have
|A0|τ 2∗ ≥ |A0|(τ 2 − (1−
√
γ)∆1); when M5 holds, we have
∑
i∈A1(x
2
i − σˆ2i − τ 2) ≥ −|A0|
√
γ∆1, thus
we have {Ec0,l,M} = {τˆ 2S0 < [τ 2 −∆1 −∆2,0]+,M} = ∅.
Proof of Theorem 3.7
Proof. As τˆ 2Sk is non-decreasing, and in order for a point to be removed at any iteration k, it must
be greater than τˆ 2SK : x
2
i ≥ F˜−1i (α2)(τˆ 2Sk + σˆ2i )⇒ x2i − σˆ2i > τˆ 2Sk ≥ τˆ 2SK . Let S0K = SK ∩ A0, we have∑
i∈S0K
(x2i − σˆ2i ) ≤ |A0|τ 2∗ − (|A0| − |S0K |)τˆ 2SK
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For a point i ∈ A1, in order for it to not be removed, it need to satisfy the following criterion:
x2i ≤ F˜−1i (α2)(σˆ2i + τˆ 2Sk) or x2i ≤ F˜−1i (
liα1
N
)(σˆ2i + τˆ
2
Sk
)
where li is the order of the p-value of x
2
i . As a result, at the last iteration K, we have
τˆ 2SK ≤ [
|A0|τ 2∗ − (|A0| − |SK0|)τˆ 2SK
|SK | +
∑
i∈A1 λ((
li
N
α1) ∧ α2)(σˆ2i + τˆ 2SK )
|SK | ]+
If τˆ 2SK = 0, we have proved our statement; otherwise, the term insider the positive operator is positive,
hence, for τˆ 2SK > 0, we have
(|A0| −
∑
i∈A1
λ((
li
N
α1) ∧ α2))τˆ 2SK ≤ |A0|τ 2∗ +
∑
i∈A1
λ((
li
N
α1) ∧ α2)σˆ2i (1)
We know that σˆ2i is
χ2m
m
σ2i -distributed with mean at most C and the variance at most
C
m
. Apply the
the Chebyshev’s inequality to the quantity
∑
i∈i∈A aiσˆ
2
i for set A and coefficient sequence {ai} we
have
P (
∑
i∈A1
aiσˆ
2
i ≤ C(
∑
i∈A1
ai +
√∑
i∈A1 a
2
i logN
m
))→ 1 (2)
Based on Lemma A.1, there is a constant c large enough such that for all l = 1, 2, . . . , |A1|, we have
λ( lα1
N
) ≤ c( N
α1l
)
2
5 , and
|A1|∑
l=1
λ(
lα1
N
) ≤ c
|A1|∑
l=1
(
N
lα1
)
2
5 ≤ c(N
α1
)
2
5
∫ Nγ
0
l−
2
5dl =
5c
3α
2
5
1
Nγ
3
5
|A1|∑
l=1
λ2(
lα1
N
) ≤ c2
|A1|∑
l=1
(
N
lα1
)
4
5 ≤ c2(N
α1
)
4
5
∫ Nγ
0
l−
4
5dl =
5c2
α
4
5
1
Nγ
1
5
Combine the above inequality with equation (2), we have
P
∑
i∈A1
λ((
li
N
α1) ∨ α2)σˆ2i < C
 5c
3α
2
5
1
Nγ
3
5 + γNλ(α2) +
√
(5c2α
− 4
5
1 Nγ
1
5 +Nγλ2(α2))
m
logN
→ 1
Let c1 := C
(
5c
3α
2
5
1
Nγ
3
5 + γNλ(α2) +
√
(5c2α
− 45
1 Nγ
1
5 +Nγλ2(α2))
m
logN
)
. Recall that M0 = {|τ 2 − τ 2∗ | ≤
(1−√γ)∆1} happens with probability approaching 1 from Lemma A.2. For any δ > 0, we have
lim
N→∞
P (τˆ 2 ≤ τ 2 + δ(τ 2 + C),M0)
≤ lim
N→∞
P (
(1− γ)(τ 2 + ∆1) + c1
1− γλ(α2)− 5a3 γ
3
5α
− 2
5
1
< τ 2 + δ(τ 2 + C))− lim
N→∞
P (M c0)− lim
N→∞
P (
∑
i∈A1
λ((
li
N
α1) ∨ α2)σˆ2i > c1)
= lim
N→∞
P (
(1− γ)(τ 2 + ∆1) + c1
1− γλ(α2)− 5a3 γ
3
5α
− 2
5
1
< τ 2 + δ(τ 2 + C))
= lim
N→∞
P (
(γλ(α2) +
5a
3
γ
3
5α
− 2
5
1 − γ)τ 2 + (1− γ)∆1 + c1
1− γλ(α2)− 5a3 γ
3
5α
− 2
5
1
< δ(τ 2 + C)) = 1
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Proof of Theorem 3.8
Proof. Let R0 and R1 be the number of rejected nulls and non-nulls using level α1(note that R1 is
the R1K in Theorem 3.5). Define Vi = 1{Hi rejected} for each i ∈ A0, pi be the p values calculated using
τˆ 2. We can express the FDR as
FDR =
|A1|∑
l=0
|A0|∑
l0=1
E[1R1=l1R0=l0
∑
i∈A0 Vi
l + l0
] =
|A1|∑
l=0
|A0|∑
l0=1
E[1R1=l1R0=l0
∑
i∈A0 1pi≤( l+l0N α1)∧α2
l + l0
]
We can further decompose the expression for FDR into two parts
FDR =
|A1|∑
l=0
|A0|∑
l0=1
E[1R1=l1R0=l01τˆ2≥τ2
l
∑
i∈A0 1pi≤( l+l0N α1)∧α2
l + l0
]︸ ︷︷ ︸
I1
+
|A1|∑
l=0
|A0|∑
l0=1
E[1R1=l1R0=l01τˆ2<τ2
l
∑
i∈A0 1pi≤( l+l0N α1)∧α2
l + l0
]︸ ︷︷ ︸
I2
By Theorem 3.5, we know I2 ≤ P (∪|A1|l=0 {R1 = l, τˆ 2 < τ 2l })→ 0, and we need only to bound I1. Let
Fi = {x21, . . . , x2i−1, x2i+1, . . . , x2N , σˆ21, . . . , σˆ2i−1, σˆ2i+1, . . . , σˆ2N}. Notice that
• Let us take x2i and σˆ2i and set their value to ∞ and 0, and denote new number of rejections for
the null and non-null by R˜0 and R˜1. If pi is rejected, we know τˆ
2 is not calculated using x2i or
σˆ2i . This new number of rejections is exactly R0 and R1 if we have rejected hypothesis i:
{R1 = l, R0 = l0, pi ≤ α1(l + l0)
N
∧α2, τˆ 2 ≥ τ 2l } = {R˜1 = l, R˜0 = l0, pi ≤
α1(l + l0)
N
∧α2, τˆ 2 ≥ τ 2l }
We take the expectation conditional on Fi:
I1 =
∑
i∈A0
|A1|∑
l=0
|A0|∑
l0=1
E[1R˜1=l1R˜0=l0E[
1
pi≤α1(l+l0)N ∧α2
(l + l0)
1τˆ2≥τ2l |Fi]]
≤
∑
i∈A0
|A1|∑
l=0
|A0|∑
l0=1
E[1R˜1=l1R˜0=l0E[
1
pi,l≤α1(l+l0)N ∧α2
(l + l0)
|Fi]]
=
∑
i∈A0
|A1|∑
l=0
|A0|∑
l0=1
E[1R˜1=l1R˜0=l0E[
1
pi,l≤α1(l+l0)N ∧α2
(l + l0)
]] (3)
By Lemma A.1, part (2), we know limN→∞ supi∈A0 supl≥0 supα≥min
(
α2,
(l∨1)α1
N
) P (pi,l≤α)
α
= 1. As a
result, for any δ > 0, there exists a N0 such that for all N > N0, we have
sup
l≥0
sup
l0≥1
P (pi,l ≤ ( l + l0
N
α1) ∧ α2) ≤ (1 + δ)( l + l0
N
α1) ∧ α2
Rearrange the righthand side of equation (3), we have I1 ≤ (1 + δ)α1 for any δ > 0. Hence
limN→∞ I1,1 ≤ α1 and limN→∞ FDR ≤ α1.
Proof of Theorem 3.10
Proof. From Theorem 3.7, for any δ1 > 0, we know M = {τˆ 2 ≤ τ 2 + δ1(τ 2 + C)} happens with
probability approaching 1, which leads to the following result:
P (φi,α = 0) ≤P (x2i ≤ F˜−1i (α)(τˆ 2 + σˆ2i ),M) + P (M c)
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≤P (z2i ≤
F˜−1i (α)(τ
2 + σˆ2i + δ1(τ
2 + C))
τ 2i + σ
2
i
)︸ ︷︷ ︸
Ii,α
+P (M c)
We now prove that Ii,α is no much larger than the oracle loss. We know that there exists a constant
fmax ≥ supt dP (z
2
i≤t)
dt
, and for any δ2, there is a constant w large enough such that
sup
δ>0
sup
i∈A1
P (z2i ≤ w(1 + δ))
P (z2i ≤ w)(1 + δ)
≤ 1 + δ2
For any α, we either have
F˜−1i (α)(τ
2+C)
τ2i +σ
2
i
≤ w√
δ1
or not. If
F˜−1i (α)(τ
2+C)
τ2i +σ
2
i
≤ w√
δ1
, we have Ii,α ≤ P (φ∗i =
0) + wfmax
√
δ1. If
F˜−1i (α)(τ
2+C)
τ2i +σ
2
i
> w√
δ1
, we have
Ii,α ≤
∫ ∞
√
δ1C
P (z2i ≤
F˜−1i (α)(τ
2 + y)
τ 2i + σ
2
i
)(
τ 2 + y + δ1(τ
2 + C)
τ 2 + y
)fσˆ2i (y)dy + P (σˆ
2
i ≤
√
δ1C) + δ2
≤P (φ∗i,α = 0) +
∫ ∞
0
P (x¯2i ≤ F˜−1i (α)(τ 2 + y))
δ1(C + τ
2)
y + τ 2
fσˆ2i (y)dy︸ ︷︷ ︸
I1
+P (σˆ2i ≤ δ1σ2i ) + δ2
In the integral I1, because P (x
2
i ≤ F˜−1i (α)(τ 2 + σˆ2i + y)) is an increasing function in y while δ1(C+τ
2)
y+τ2
is a decreasing function in y, we have
I1 ≤ P (φ∗i = 0)
∫ ∞
0
δ1(C + τ
2)
y + τ 2
fσˆ2i (y)dy
σˆ2i is
χ2m
mσ2i
distributed, the expectation of its inverse is m
(m−2) , Recall that minσ
2
i = 1:∫ ∞
0
δ1(C + τ
2)
y + τ 2
fσˆ2i (y)dy ≤
∫ ∞
0
(
δ1C
y
+ δ1)fσˆ2i (y)dy = δ1(1 +
Cm
m− 2)
As a result, we have
P (φi,α = 0)− P (φ∗i = 0) ≤ max
i∈A1
(
√
δ1wfmax, δ1 + δ1
Cm
m− 2 + P (σˆ
2
i ≤
√
δ1C) + δ2) + P (M
c)
The left-hand-side of the above expression does not depend of i or α. For any δ > 0, we can take N
large enough and δ1, δ2 small enough such that
δ1 + δ1
Cm
m− 2 + maxi∈A1 P (σˆ
2
i ≤
√
δ1C) + δ2 + P (M
c) < δ,
√
δ1wfmax + P (M
c) < δ
Hence, we have limN→∞ supi∈A1 supα≥0(P (φi,α = 1)− P (φ∗i,α = 1)) ≥ 0.
B Proof of Lemmas A.1, A.2
Proof of Lemma A.1
Proof. (1) Let 1− T˜m(.) be the cumulative function of a t distribution with m degree of freedom and
1 − Φ˜(.) be the cumulative function of a normal. Let tm(.) and φ(.) be there density function. We
first show that for any fixed value t ≥ 0, we have
2Φ˜(
√
t) ≤ F˜i(t) ≤ 2T˜m(
√
t) (4)
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Let a(τ 2) := P (
x2i
τ2+σˆ2i
≥ t) = P ( (τ2+σ2i )z2
τ2+σ2i u
≥ t), where z be a random variable with standard normal
distribution and u be a random variable distributed as χ
2
m
m
, z and u are independent. The function
a(τ 2) has a non-positive first derivative with respect to τ 2:
da(τ 2)
dτ 2
=
d
dτ 2
∫ ∞
0
∫
z2≥ t(τ
2+uσ2
i
)
τ2+σ2
i
φ(z)dzfu(u)du
=
∫ ∞
u=0
fu(u)φ(
√
t(τ 2 + uσ2i )
τ 2 + σ2i
)
√
τ 2 + σ2i
t(τ 2 + uσ2i )
σ2i t(u− 1)
(τ 2 + σ2i )
2
du
∝
∫ ∞
u=0
fu(u)e
− t(τ
2+uσ2i )
τ2+σ2
i
√
1
τ 2 + uσ2i
(u− 1)du
The expected value of u is 1:
∫∞
x=0
fu(x)(u − 1) = 0 and e
− t(τ
2+uσ2i )
τ2+σ2
i
√
1
τ2+uσ2i
is a decreasing function
of u, thus a(τ 2) has a non-positive first derivative with respect to τ 2. For any fixed t ≥ 0, we have
a(∞) ≤ P ( x
2
i
τ 2 + σˆ2i
≥ t) ≤ a(0)
We use the fact that a(∞) = 2Φ˜(√t) and a(0) = 2T˜m(
√
t) to get equation (4). It is also easy to
check that for any fixed non-negative t, T˜m(t) is non-increasing in m because when m1 < m2, the
density ratio between the t-distribution with degree of freedom m1 and that with degree of freedom
m2 is non-decreasing in the positive part and non-increasing in the negative part. As a result, T˜m(t)
is non-increasing in m for any fixed t and F˜i(t) ≤ 2T˜5(
√
t). Apply the Mill’s ratio result for the
t-distribution(Soms (1976)):
T˜m(t) <
tm(t)
t
(1 +
t2
m
) (5)
we have
F˜ (t) ≤ 2Γ(
m+1
2
)√
pimtΓ(m
2
)
(1 +
t
m
)−
m−1
2 <
√
2
pi
(
t
m
)−
m
2 → λ( lα1
N
) . ( N
lα1
)
2
5
As a direct result, we have ∆1
τ2+1
λ(α1
N
) → 0. Because ∆2,l ≤ α2 log( 1α2 ), we have λ(α2)α2 log 1α2 → 0,
hence supl≥0 ∆2,lλ(λ2)→ 0. The result supl≥1 ∆2,lτ2+1λ( lα1N )→ 0 also holds because
• If l
N
is a positive constant,
∆2,l
τ2+1
→ 0 because α2 → 0.
• If l
N
→ 0 and l
N
& log2 N
N
,
∆2,l
τ2+1
. l
N
log N
l
, λ( lα1
N
)
∆2,l
τ2+1
→ 0.
• If l
N
. log2N
N
,
∆2,l
τ2+1
. log2 N
N
log N
log2N
and N
2
5
∆2,l
τ2+1
→ 0, hence we still have λ( lα1
N
)
∆2,l
τ2+1
→ 0.
(2)Based on part (1) and the fact that ∆2,0 ≤ ∆2,1, let α3 = min
(
α2,
(l∨1)α1
N
)
, we have:
sup
l≥0
sup
α≥α3
∆1 + ∆2,l
τ 2 + 1
λ(α)→ 0 (6)
Because τ 2l ≤ τ 2, we always have P (pi,l≤α)α ≥ 1, and we need only to check that, for any δ > 0,
P (pi,l≤α)
α
≤ 1 + δ holds uniformly for large N . We break the expression in the statement into two
parts:
sup
i,l
sup
α≥α3
P (pi,l ≤ α))/α = sup
i,l,α
∫ ∞
y=0
P (x2i ≥ (y + τ 2l )F˜−1i (α))fσˆ2i (y)dy/α = sup
i,l,α
(I1,i,l,α + I2,i,l,α)
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where I1,i,l,α =
∫
y+τ2
τ2+C
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2l )F˜−1i (α))fσˆ2i (y)dy/α and I2,i,l,α =
∫
y+τ2
τ2+C
F˜−1i (α)≤ 1δ
P (x2i ≥
(y+τ 2l )F˜
−1
i (α))fσˆ2i (y)dy/α, with δ being any positive constant. For I1,i,l,α, we use the following Mill’s
result for the normal(Gordon (1941))
t
t2 + 1
φ(t) < Φ˜(t) <
φ(t)
t
(7)
to upper bound P (x2i ≥ (y + τ 2l )F˜−1i (α)) and lower bound P (x2i ≥ (y + τ 2)F˜−1i (α)) in terms of the
density:
I1,i,l,α ≤
∫
y+τ2
τ2+C
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))
τ 2 + σ2i + (y + τ
2)F˜−1i (α)
(y + τ 2l )F˜
−1
i (α)
e
(∆1+∆2,l)F˜
−1
i
(α)
2(τ2+σ2
i
) fσˆ2i (y)dy/α
≤
∫
y+τ2
τ2+C
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))(1 +
τ 2 + σ2i + (∆1 + ∆2,l)F˜
−1
i (α)
(y + τ 2l )F˜
−1
i (α)
)e
(∆1+∆2,l)F˜
−1
i
(α)
2(τ2+σ2
i
) fσˆ2i (y)dy/α
For I2,i,l,α:
I2,i,l,α −
∫
y+τ2
τ2+C
F˜−1i (α)≤ 1δ
P (x2i ≥ (y + τ 2)F˜−1i (α))fσˆ2i (y)dy/α
=
∫
y+τ2
τ2+C
F˜−1i (α)≤ 1δ
(
P (x2i ≥ (y + τ 2l )F˜−1i (α))− P (x2i ≥ (y + τ 2)F˜−1i (α))
)
fσˆ2i (y)dy/α
Recall that P (x2i ≥ (y+τ 2)F˜−1i (α)) = 2Φ˜(
√
(y+τ2)F˜−1i (α)
τ2+σ2i
) and P (x2i ≥ (y+τ 2l )F˜−1i (α)) = 2Φ˜(
√
(y+τ2l )F˜
−1
i (α)
τ2+σ2i
),
we can bound the difference by the product of the difference in the interval length and the upper
bound of the normal density
2Φ˜(
√
(y + τ 2l )F˜
−1
i (α)
τ 2 + σ2i
)− 2Φ˜(
√
(y + τ 2)F˜−1i (α)
τ 2 + σ2i
) ≤ 2
√
1
2pi
(
√
(y + τ 2)F˜−1i (α)
τ 2 + σ2i
−
√
(y + τ 2l )F˜
−1
i (α)
τ 2 + σ2i
)
We know that for any positive value x, y, we have
√
x+ y ≤ √x+√y, as a result, we have
2Φ˜(
√
(y+τ2l )F˜
−1
i (α)
τ2+σ2i
)− 2Φ˜(
√
(y+τ2)F˜−1i (α)
τ2+σ2i
)
2Φ˜(
√
(y+τ2)F˜−1i (α)
τ2+σ2i
)
≤
√
(τ2−τ2l )F˜−1i (α)
2pi(τ2+σ2i )
Φ˜(
√
(y+τ2)F˜−1i (α)
τ2+σ2i
)
In other words, we have
I2,i,l,α ≤
∫
y+τ2
τ2+C
F˜−1i (α)≤ 1δ
P (x2i ≥ (y + τ 2)F˜−1i (α))(1 +
√
(τ2−τ2l )F˜−1i (α)
2pi(τ2+σ2i )
Φ˜(
√
C
δ
)
)fσˆ2i (y)dy/α
Combine them together and apply equation (6), we have
sup
i,l,α
(I1,i,l,α + I2,i,l,α − 1) ≤ sup
i,l,α
(
∫
y+τ2
C+τ2
F˜−1(α)≤ 1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))
√
(∆1+∆2,l)F˜−1(α)
2pi(τ2+C)
Φ˜(
√
C
δ
)
fσˆ2i (y)dy/α
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+∫
y+τ2
C+τ2
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))
τ 2 + σ2i + (∆1 + ∆2,l)F˜
−1
i (α)
(y + τ 2l )F˜
−1
i (α)
e
(∆1+∆2,l)F˜
−1
i
(α)
2(τ2+σ2
i
) fσˆ2i (y)dy/α)
→ sup
i,l,α
∫
y+τ2
C+τ2
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))
τ 2 + σ2i
(y + τ 2l )F˜
−1
i (α)
fσˆ2i (y)dy/α
≤ sup
i,l,α
∫
y+τ2
C+τ2
F˜−1i (α)>
1
δ
P (x2i ≥ (y + τ 2)F˜−1i (α))
τ 2 + C
(τ2+C)
δ
− (∆1 + ∆2,l)F˜−1i (α)
fσˆ2i (y)dy/α
→ sup
i,α
∫
y+τ2
C+τ2
F˜−1i (α)>
1
δ
δP (x2i ≥ (y + τ 2)F˜−1i (α))fσˆ2i (y)dy/α < δ
As it holds for any δ > 0, we have limN→∞ supi∈A0 supl≥0 supα≥min
(
(α2∨ log2 NN ),
(l∨1)α1
N
) P (pi,l≥α)
α
= 1
(3) At k + 1th iteration, for every point we removed, they need to satisfy that x2i ≥ F˜−1i (α1)(τˆ 2Sk +
σˆ2i ). From equation (4), we have(recall that α1 <
1
2e
):
F˜−1(α1) ≥ (Φ˜−1(α1
2
))2 > 1
as a result, x2i − σˆ2i ≥ τˆ 2Sk ⇒ the τ 2 estimate is non-increasing.
Proof of Lemma A.2
Proof of M0 happening with probability approaching one: We know that σˆ
2
i ∼ σ2i χ
2
m
m
and
x2i ∼ (τ 2 + σ2i )χ21. Because σ2i ≤ C, we have E[x2i − σˆ2i ] = τ 2 and V ar[x2i − σˆ2i ] ≤ τ 2 + (1 + 1m)C.
Result follows from the Chebyshev’s inequality.
Proof of M1 happening with probability approaching one: For the event M1, consider the
event Ak,l := {|B1,l| = k}. Use Lemma A.1 part (2), and take δ < 12eα1 − 1, for large enough N :
sup
i∈A0
sup
l≥0,k≥1
P (pi,l ≤ (l+k)α1N )
(l+k)α1
N
< 1 + δ (8)
Event Ak,l is contained in the event that there are k null p-values at most
(l+k)α1
N
, hence, P (Ak,l) ≤( |A0|
k
)
( l+k
N
(1 + δ)α1)
k. Let kl := d|A0|max( lN , log
2 N
N
)e, for l = 0, 1, . . . , |A1|, we have
P (M c1) ≤
|A1|∑
l=0
∑
k≥kl
( |A0|
k
)
(
l + k
N
(1 + δ)α1)
k
Let ak,l =
( |A0|
k
)
(k+l
N
(1 + δ)α1)
k, uk,l =
k+l
k
. It is easy to check that uk,l is decreasing in k
and x 7→ xe1/x is increasing on [1,∞]. For k ≥ kl ≥ (1 − γ)l, we have that uk,l ≤ 21−γ , and
(1 + 1
k+l
)k ≤ e1/uk,l , as log(1 + 1
k+l
)k = k log(1 + 1
k+l
) ≤ k
k+l
. Hence, for large N and any l considered,
ak,l is non-increasing in k when k ≥ kl:
sup
l,k
ak+1,l
ak,l
= sup
l,k
(|A0| − k)
k + 1
(k + l + 1)(1 + δ)α1
N
(1 +
1
k + l
)k
≤ sup
l,k
(1− γ)(1 + δ)α1uk,le
1
uk,l
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≤(1− γ)(1 + δ)α1 2
1− γ e
1−γ
2 < 2
√
e(1 + δ)α1 < 1
Using sterling’s approximations to upper bound al,kl , the probability of M
c
1 can be bounded as
P (M c1) ≤
|A1|∑
l=0
|A0|al,dkle ≤
|A1|∑
l=0
|A0| |A0|
kl+|A0|−kl
kkll (|A0| − kl)|A0|−kl
(
kl + l
N
(1 + δ)α1)
kl
=
|A1|∑
l=0
|A0| |A0|
|A0|−kl
(|A0| − kl)|A0|−kl (
|A0|
N
)kl(
kl + l
kl
(1 + δ)α1)
kl
=
|A1|∑
l=0
|A0| exp(kl log(ukl,l(1− γ)(1 + δ)α1) + (|A0| − kl) log
|A0|
|A0| − kl )
≤
|A1|∑
l=0
|A0| exp
(
kl log(2(1 + δ)α1) + (|A0| − kl) log |A0||A0| − kl
)
The quantity inside the exponential is a decreasing function of kl, as its derivative is
(log(2(1 + δ)α1) + 1 + log(
|A0| − kl
|A0| ) < 0
Thus, for all l, it is less than or equal to its value at kl = d log2 NN |A0|e. For kl = d log
2N
N
|A0|e, we have
(|A0| − kl) log |A0||A0|−kl = kl(o(1) + 1), and P (M1) ≥ 1−N2ekl(log(2(1+δ)α1)+1+o(1)) → 1.
Proof of M2 happening with probability approaching one: For the event M2, we only need to
check B2,|A1| because B2,l ⊆ B2,l′ for all l ≤ l′. By Lemma A.1 part (2), supi supl P (pi,l≤α2)α2 ≤ (1 + δ).
As a result, |B2,|A1|| is at most y ∼Bin(|A0|, (1 + δ)α2). The variable y has mean (1 + δ)α2|A0|
and variance bounded by (1 + δ)α2|A0|. We apply Chebyshev’s inequality and reach our conclusion
P (M2) = P (|B1,Nγ| ≤ 2α2|A0|) ≥ P (y ≤ 2α2|A0|) ≥ 1− (1+δ)(1−δ)2α2|A0| → 1.
Proof of M3 happening with probability approaching one: Let x˜
2
α be the upper α
th quantile
of {x2i , i ∈ A0}. It is sufficient to consider Aα, the set of x2i whose value is no smaller than x˜α, so
|Aα| = dα|A0|e. Let D1 = {∀l = 0, 1, . . . , |A1|, x˜
2
tl
2(τ2+C) log 1
tl
≤ 1}. Let z be a standard normal variable.
For each i ∈ A0, we have P (x2i ≥ 2(τ 2 + C) log 1tl ) ≤ P (z2 ≥ 2(τ 2 + C) log 1tl ) = 2Φ˜(
√
2 log 1
tl
)
eq.(7)
≤
tl√
pi log 1
tl
. Because |A0| > cN for some positive constant c and tl ∈ [ log2NN , α2), we apply the sterling’s
approximations:
P (Dc1) ≤ N
|A1|
max
l=0
( |A0|
d|A0|tle
)
P (x2i ≥ 2(τ 2 + C) log
1
tl
)d|A0|tle ≤ |A1|max
l=0
N( tl√
pi log 1
tl
)|A0|tl
t
|A0|tl
l (1− tl)|A0|−|A0|tl
As tl goes to 0 in l, for large enough N , we have
1
t
|A0|tl
l (1− tl)|A0|(1−tl)
= exp (−|A0|tl log tl − |A0|(1− tl) log(1− tl)) ≤ exp(−|A0|tl log tl + 2|A0|tl)
As tl ≥ log2NN , |A0| > cN , for N large enough, we have P (Dc1) ≤ N exp(|A0|tl(2− 12 log log 1tl ))→ 0.
Now we show M3 happens high probability. As tl ≥ log2NN and |A0| > cN , for N large enough,
we have 0.3(τ 2 + C)tl|A0| log 1tl ≥ 8(τ 2 + C) logN . Let M ′3 = {∀l = 0, 1, . . . , |A1|,
∑
i∈Atl x
2
i ≤
21
2.2(τ 2 +C)tl|A0| log 1tl + 8(τ 2 +C) logN}, we have M ′3 ⊆M3 for large N . Let A˜tl be nulls such that
x2i ≥ 2(τ 2 + C) log 1tl . When D1 is true, if x2i exceeds 2(τ 2 + C) log 1tl , it must also exceeds x˜2tl , in
other words, A˜tl ⊆ Atl . Since |Atl | = dtl|A0|e and x2i − 2.2(τ 2 + C) log 1tl < 0 for i 6= A˜tl , for N large
enough:
{M ′2, D1} ={∀l = 0, 1, . . . , |A1|,
∑
i∈Atl
x2i ≤ 2.2(τ 2 + C)tl|A0| log
1
tl
+ 8(τ 2 + C) logN,D1}
⊆{∀l = 0, 1, . . . , |A1|,
∑
i∈A˜tl
(x2i − 2.2(τ 2 + C) log
1
tl
)
︸ ︷︷ ︸
Il
) ≤ 8(τ 2 + C) logN} ∩D1
Let wi =
τ2+C
τ2+σ2i
∈ [1, C], zi = xi√
τ2+σ2i
∼ N(0, 1) for i ∈ A0. Rearrange Il:
Il =
∑
i∈A0
(x2i − 2.2(τ 2 + C) log
1
tl
)1x2i≥2(τ2+C) log 1tl
= (τ 2 + C)
∑
i∈A0
1
wi
(z2i − 2.2wi log
1
tl
)1z2i≥2wi log 1tl
Let yi :=
1
wi
(z2i − 2.2wi log 1tl )1z2i≥2wi log 1tl . The moment generating function of yi is(λ <
wi
2
):
Myi(λ) = 2
∫
zi≥
√
2wi log
1
tl
exp(
1
wi
(z2i − 2.2wi log
1
tl
)λ)
1√
2pi
exp(−z
2
i
2
)dzi + P (z
2
i ≤ 2wi log
1
tl
)
=
2√
1− 2 λ
wi
exp(−2.2λ log 1
tl
)Φ˜(
√
(1− 2 λ
wi
)2wi log
1
tl
) + (1− 2Φ˜(
√
2wi log
1
tl
))
By the Mill’s ratio bound (7), we have
Myi(λ) ≤ 1 + 2twil (
t0.2λl
(1− 2 λ
wi
)
√
4wipi log
1
tl
−
√
2wi log
1
tl√
2pi(1 + 2wi log
1
tl
)
)
Take λ = 1
4
. Because we have tl → 0 over l, for N large enough, we have Myi(14) ≤ 1. As a result,
for N large enough: P (Il ≥ 8(τ 2 + C) logN) = P (
∑
i∈A0 yi ≥ 8 logN) ≤
∏
i∈A0 (Myi (
1
4
))
exp(2 logN)
≤ 1
N2
, and
P (
|A1|
max
l=0
Il ≤ 8(τ 2 + C) logN)→ 1⇒ P (M ′3)→ 1⇒ P (M3)→ 1
Proof of M4 and M5 happening with probability approaching one: For a small constant c, we
define I1,l =
∑
i∈A1(x
2
i−σˆ2i−τ 2l )1σˆ2i≥c1x2i≤F˜−1i (α2)(τ2l +σˆ2i ) and I2,l =
∑
i∈A1(x
2
i−σˆ2i−τ 2l )1σˆ2i<c1x2i≤F˜−1i (α2)(τ2l +σˆ2i ).
We want to show I1,l + I2,l ≥ −(τ 2 + 1)(1− γ)
√|A1| logN for all l with high probablity. Let  and L
be the constants in Assumption 3.2. We have τ 2l ≤ τ 2 and for the smallest τ 2|A1|, we have
τ2−τ2|A1|
τ2+1
→ 0.
As α2 → 0, for large enough N , we have (F˜−1i (α2)− 1− )(τ 2l + 1) > L(τ 2 + 1) and
{x2i − (1 + )σˆ2i ≤ L(τ 2 + 1)} ∩ {σˆ2i ≥ c} ⊆ {x2i ≤ F˜−1i (α2)(τ 2l + σˆ2i )} ∩ {σˆ2i ≥ c}
If we include any point in {x2i − (1 + )σˆ2i ≥ L(τ 2 + 1)}, we increase I1,l. Using also τ 2 ≥ τ 2l ,
we have Il,1 ≥
∑
i∈A1(x
2
i − σˆ2i − τ 2)1σˆ2i≥c1x2i−(1+)σˆ2i≤L(τ2+1). If we include any point in {x2i −
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(σˆ2 + τ 2l ) ≥ 0}, we increase I2. Thus, we have I2 ≥ −(c + τ 2l )
∑
i∈A1 1σˆ2i<c1x2i−(σˆ2+τ2l )≤0 ≥ −(c +
τ 2)
∑
i∈A1 1σˆ2i<c1x2i−(1+)σˆ2≤L(τ2+1). Hence, we have
I1,l + I2,l ≥
∑
i∈A1
[(x2i − σˆ2i − τ 2)1σˆ2i≥c − (τ 2 + c)1σˆ2i<c]1x2i−(1+)σˆ2≤L(τ2+1)
The lower bounds no longer involve l. Let yi = [(x
2
i − σˆ2i − τ 2)1σˆ2i≥c− (τ 2 + c)1σˆ2i<c]1x2i−(1+)σˆ2i≤L(τ2+1)
and let A˜ = {i : x2i − (1 + )σˆ2i ≤ L(τ 2 + 1)}, we have E[yi] = P (A˜)E[(x2i − σˆ2i − τ 2)1σˆ2i≥c − (τ 2 +
c)1σˆ2i<c|A˜]. For any y ≥ 0, we have
E[1σˆ2i<y|A˜] =
∫
t≥0
P (σˆ2i ≤ y|(1 + )σˆ2i ≥ t− (L+ 1))dP (x2i > t) ≤
∫
t≥0
P (σˆ2i ≤ y)dP (x2i > t) = P (σˆ2i ≤ y)
E[σˆ2i |A˜] =
∫
y≥0
ydP (σˆ2i > y|A˜) ≥
∫
y≥0
ydP (σˆ2i > y) = E[σˆ
2
i ]
E[x2i1σˆ2i<c|A˜] = P (σˆ2i < c)
∫ ∞
t=0
E[x2i |x2i ≤ (1 + )t+ L(τ 2 + 1)]
dP (σˆ2i < t|σˆ2i ≤ c)
dP (σˆ2i < t)
dP (σˆ2i < t)
Because E[x2i |x2i ≤ (1 + )t + L(τ 2 + 1)] is non-decreasing in t and dP (σˆ
2
i<t|σˆ2i≤c)
dP (σˆ2i<t)
is non-increasing in
t, we have
E[x2i1σˆ2i<c|A˜] ≤ P (σˆ2i < c)
∫ ∞
t=0
E[x2i |x2i ≤ (1 + )t+ L(τ 2 + 1)]dP (σˆ2i < t) = P (σˆ2i < c)E[x2i |A˜]
We can now lower bound E[(x2i − σˆ2i − τ 2)1σˆ2i≥c|A˜]:
E[(x2i − σˆ2i − τ 2)1σˆ2i≥c|A˜] ≥ E[x2i − σˆ2i |A˜]− E[x2i1σˆ2i<c|A˜]− τ 2 ≥ E[x2i − σˆ2i |A˜]− P (σˆ2i < c)E[x2i |A˜]− τ 2
By Assumption 3.2, we have E[x2i − (1 + )σˆ2i |A˜] ≥ (1 + )τ 2, if we take c small enough such that
maxi∈A1 P (σˆ
2
i < c) ≤ 2(1+) , we have
E[yi] ≥ E[x2i − σˆ2i |A˜]− P (σˆ2i < c)E[x2i |A˜]− τ 2
≥ (1− 
2(1 + )
)E[x2i − (1 + )σˆ2i |A˜] +

2
E[σˆ2i |A˜]− τ 2
≥ (1− 
2(1 + )
)(1 + )τ 2 − τ 2 + 
2
> 0
We can also bound E[y2i ]:
E[y2i ] = E[(x
2
i − σˆ2i − τ 2)21σˆ2i≥c1A˜ + (τ 2 + c)21σˆ2i<c1A˜]
When A˜ is true, (x2i − σˆ2i − τ 2)2 ≤ max((σˆ2i + τ 2)2, (L(τ 2 + 1) + σˆ2i )2), therefore, we have
E[y2i ] ≤ (τ 2 + c)2 + E[(σˆ2i + τ 2)2] + E[(L(τ 2 + 1) + σˆ2i )2]
≤ (τ 2 + 1)2 + (1 + 2)E[σˆ4i ] + (1 + L2)(τ 2 + 1)2 + 2(τ 2 + L(τ 2 + 1))E[σˆ2i ]
≤ (1 + L2 + (1 + 2)C2(1 + 1
m
) + 2(L+ 2)C)(τ 2 + 1)2
We apply the Chebyshev’s inequality to
∑
i∈A1 yi:
P (
∑
i∈A1
yi ≥ −(1− γ)
√
|A1| logN(τ 2 + 1))→ 1
As we have I1,l + I2,l ≤
∑
i∈A1 yi holds for all l, hence, P (M4) → 1. For the event M5, we have∑
i∈A1(x
2
i − σˆ2i − τ 2) ≤
∑
i∈A1(x
2
i − σˆ2i − τ 2)1A˜ ≤
∑
i∈A1 yi. Therefore P (M5)→ 1.
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C Estimation procedures
In this section, we give the details of the truncated MLE estimate and the CM estimate of the
spreading factor τ 2.
Truncated MLE: Let C be a normalization constant depending on the context, the likelihood
function of the observed points from null distribution with mean level µi in terms of sufficient statistics
x¯i and σˆ
2
i (σˆ
2
i = mσˆ
2
x¯i
) is
f = C
∏
i∈A0
(τ 2)−
1
2σ
−(m−k)
i e
− (x¯i−µi)
2
2τ2 e
− (m−k)σˆ
2
i
2σ2
i
marginalized out µi:
f = C
∏
i∈A0
(τ 2 + σ2x¯i)
− 1
2σ
−(m−k)
i exp(−
(m− k)σˆ2i
2σ2i
− x¯
2
i
2(τ 2 + σˆ2x¯i)
) (9)
For points in A0 with mean difference x¯i in (−δ0, δ0), for a positive value δ0, this truncated likelihood
function is:
ftruncated = C
∏
i∈A0,x¯i∈(−δ0,δ0)
I[x¯i∈(−δ0,δ0)]
H(τ 2, σ2x¯i)
(τ 2 + σ2x¯i)
− 1
2σ
−(m−k)
i exp(−
(m− k)σˆ2i
2σ2i
− x¯
2
i
2(τ 2 + σˆ2x¯i)
)
where
H(τ, σ2x¯i) =
∫
x∈[−δ0,δ0]
1√
2pi(τ 2 + σ2x¯i)
exp(− x
2
2(τ 2 + σ2x¯i)
)
Assuming that the observed {x¯i,∀i ∈ A1} will not fall into the range (−δ0, δ0), we have
ftruncated = C
∏
x¯i∈(−δ0,δ0)
I[x¯i∈(−δ0,δ0)]
H(τ 2, σ2x¯i)
(τ 2 + σ2x¯i)
− 1
2σ
−(m−k)
i exp(−
(m− k)σˆ2i
2σ2i
− x¯
2
i
2(τ 2 + σˆ2x¯i)
)
ltruncated = − log ftruncated
= C +
N∑
i=1
I[x¯i∈(−δ0,δ0)](logHi +
log(τ 2 + σ2x¯i)
2
+
m− k
2
log σ2i +
(m− k)σˆ2i
2σ2i
+
x¯2i
2(τ 2 + σ2x¯i)
) (10)
We can find the minimizer to the above target function by iteratively updating τ 2 and {σ2i : −δ0 ≤
x¯i ≤ δ0}. We start from τ 2 = 0 and do the following,
For τ 2 fixed, solutions to {σ2i } :
σˆ2i = arg min
σ2i
logHi +
log(τ 2 + σ2x¯i)
2
+
m− k
2
log σ2i +
(m− k)σˆ2i
2σ2i
+
x¯2i
2(τ 2 + σ2x¯i)
For {σ2i } fixed, solution to τ 2 :
τˆ 2i = arg min
τ2
N∑
i=1
I[x¯i∈(−δ0,δ0)](logHi +
log(τ 2 + σ2x¯i)
2
+
x¯2i
2(τ 2 + σ2x¯i)
)
CM: The marginal density of x¯i(marginalized over the index i) for all genes can be written as
following
f(x|τ) ∼ 1
N
∑
i∈A0
e
− x2
2(σ2x¯i
+τ2)√
2pi(σ2x¯i + τ
2)
+
1
N
∑
i∈A1
hi(x) (11)
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where hi(.) is the density function for x¯i when i ∈ A1, which is gi(µ) convolved with the a normal
distribution describing the noise in x¯i: hi(x) =
∫
gi(µ)
1√
2piσ2x¯i
e
− (x−µ)2
2σ2x¯i dµ.
Like in truncated MLE method, we assume that A1’s contribution to the region [−δ0, δ0] is negeli-
giable. Doing a first order Taylor expansion of the marginal density function f(x|τ), we have
f(x|τ) ≈ 1
N
N∑
i=1
1√
2pi(σ2x¯i + τ
2)
(1− x
2
2(σ2x¯i + τ
2)
)
l(x) = − log f(x) ≈ C +
N∑
i=1
x2
(σ2x¯i + τ
2)
3
2
∑
i∈A0
1√
σ2x¯i
+τ2
We find τ 2 by fitting a polynomial function to (x, lˆ(x)), where lˆ(x) is the negative log transforma-
tion of the empirical marginal density function, estimated by binning our observations in [−δ0, δ0]–
such binning and fitting steps are also used by the R function locfdr. As a result, we can get the
estimated τ 2 simply as following:
1. Use the R function locfdr with central matching approach to find the coefficients of the second
term in the regression fit
lˆ(x) = β0 + β1x+ β2x+ ....
and denote it as βˆ2.
2. Use the relationships below to fo a grid search of τ 2:
N∑
i=1
1
2(σ2x¯i + τ
2)
3
2
∑N
i=1
1√
σ2x¯i
+τ2
= βˆ2
with σ2x¯i replaced by σˆ
2
x¯i
.
Intuitively, the three procedures are different in several perspectives:
1. ITEB starts by treating the full data set as null and iteratively removing genes with large values,
it usually ends up estimating using a set of genes much larger than the other two methods. As
a result, it is be able to utilize more information from the data, but it suffers more from initially
overestimating τ 2 when γ is large(We care about small γ in our case).
2. CM relies on the first order Taylor expansion of the log likelihood around a small region near 0,
as well as the plug-in variance estimates, and it also needs to plug in variance estimates in the
denominator, which makes it unstable.
3. Both the truncated MLE method and CM need to know the specific form of the likelihood
for the null distribution, while ITEB uses only the moments, which makes its application to
complicated distributions straightforward. Also, both CM and truncated MLE have removed
a significant proportion of data from the beginning, and as a result, their estimates can have
larger variance compared with that of ITEB when γ is small.
In Appendix D, we compare performances for the three estimates in different scenarios and discuss
their strengths and weaknesses.
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D Simulation: Estimate of τ
For simplicity, we focus on the one-sample setting and and generate data under various values of
τ and non-null proportion γ = |A1|
N
. Specifically, we fix N = 15000,m = 10, which is of the
same order as typical knock-down data. For any given τ and γ, where p = 0, 1%, ..., 10% and
τ = 0, 0.1, ..., 1, 1.5, 2, 2.5, 3, we generate the data as below.
1. Generate µis: µi ∼
{
N(0, τ 2) ∀i ∈ A0
±U [1,max(3, 10τ)] ∀i ∈ A1
where U [1,max(3, 10τ)] is the uniform distribution between 1 and max(3, 10τ), and the signs of
µis will be half positive and half negative.
2. Generate variances for genes in one of the two settings:
(a) Independently generate σ2i ∼ χ21.
(b) Sample σ2i from its empirical distribution in the real data set, scaled to have mean level 1.
We used the three approaches to estimate τ with (α1, α2) = (0.1, 0.01) for ITEB and leave out
proportion to be 0.2 both for truncated MLE and CM. We repeat the simulations 20 times and
plot the relative mean relative errors
∑20
i=1 |τˆ2−τ2|
20(τ2+0.1)
in Figure 6. We have also consider the case where
the data is not normal by generating parameters in the same way but with Laplacian distributed
noise(means and variances are matched), results are given in Figure 7.
From the simulation results, we can see that (1)CM does not seem to be a good approach estimating
τ . (2) ITEB’s performance is as good as Truncated MLE, if not better, across the parameters we
have considered.
While the performances for both ITEB and truncate MLE are reasonably good, there is a huge
time difference. In our simulation, the truncated MLE’s run time is more than 100 times of that of
ITEB: the average run time per round for the ITEB is about 0.1 second, while it is 13 seconds for
the the truncated MLE.
Overall, we consider ITEB to be a good substitute for the truncated MLE estimate because of its
simplicity and good performance, and both methods are preferable over CM.
E Materials and Methods for the knock-down experiment
In this section, we provide more details about how the data is generated and justification of pooling
data across days.
Cell Culture: Mouse ES cell line R1 was obtained from Dr. Douglas Melton lab (Harvard University,
MA) and cultured under standard conditions. The cells were maintained on gelatin-coated dishes in
RPMI knockout medium with 15% knockout serum replacement (KSR), 2 mM L-glutamine, 1 mM
non-essential amino acids, 0.55 mM 2-mercaptoethanol (Invitrogen, CA), and 1000 units/mL murine
leukaemia inhibitory factor (Chemicon International, CA). Cells were incubated in a 5% CO2–air
mixture at 37oC. Cultures were routinely passaged with 0.25% trypsin-EDTA (Invitrogen, CA) and
split 1:8 every 2 days. Normal karyotype of ESC was routinely confirmed by analysis of chromosome
spreads.
RNA Interference: RNA interference (RNAi) experiments were performed with Nucleofector tech-
nology. Briefly, 12 µd of plasmid DNA was transfected into 3.5×106 mouse ES cells using the Mouse
ES cell Nucleofector kit (Lonza, Switzerland). After nucleofection, the cells were incubated in 500 µl
warm ES medium for 15 min. Then, the cells were split into four gelatin-coated 60-mm tissue culture
plates containing 5 ml of warm ES medium. Puromycin selection was introduced 18 h later at 1 µ
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Figure 6: Gaussian noise, setting (a) and (b): The left half plot is the plot of the estimated relative error versus τ
from setting (a)and the right half plot is that from setting (b)
g/ml, and the medium was changed daily. 30 h, 48 h, and 72 h after puromycin selection, the cells
were collected for RNA isolation.
Microarray and Data Processing: Microarray hybridizations were performed on the MouseRef-
8 v2.0 expression beadchip arrays (Illumina, CA). To prepare sample, 200 ng of total RNA was
reverse transcribed, followed by a T7 RNA polymerase-based linear amplification using the Illumina
TotalPrep RNA Amplification kit (Applied Biosystems, CA). After amplification, 750 ng of biotin-
labeled cRNA was hybridized to gene specific probes attached to the beads, and the expression levels
of transcripts were measured simultaneously.
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Figure 7: Laplacian noise, setting (a) and (b): The left half plot is the plot of the estimated relative error versus τ
from setting (a)and the right half plot is that from setting (b)
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